Point‐of‐Care Fluorescence Immunoassay for Cardiac Panel Biomarkers

Myoglobin, creatine kinase‐MB isoenzyme (CK‐MB), and cardiac troponin I (cTnI) are cardiac biomarkers that are widely used to assist in the early and late diagnoses of acute myocardial infarction (AMI). Here, we present a clinically applicable fluorescence (FL) immunoassay for cardiac biomarkers.

[1]  D. Levy,et al.  Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.

[2]  Fred S Apple,et al.  Analytical characteristics of high-sensitivity cardiac troponin assays. , 2012, Clinical chemistry.

[3]  R. O'Kennedy,et al.  Cardiac biomarkers and the case for point-of-care testing. , 2009, Clinical biochemistry.

[4]  Anders Larsson,et al.  Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. , 2008, The New England journal of medicine.

[5]  M. Panteghini.  The measurement of cardiac markers: where should we focus? , 2002, American journal of clinical pathology.

[6]  Leong L Ng,et al.  Biomarkers in acute myocardial infarction , 2010, BMC medicine.

[7]  Christophe Leclercq,et al.  2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[8]  Q. Shen,et al.  Differences between cardiac and skeletal troponin interaction with the thin filament probed by troponin exchange in skeletal myofibrils. , 2009, Biophysical journal.

[9]  L. Lind,et al.  Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population. , 2013, Journal of the American College of Cardiology.

[10]  R Bellomo,et al.  Point-of-care testing during medical emergency team activations: a pilot study. , 2012, Resuscitation.

[11]  Kie Bong Nahm,et al.  Simplified laser fluorescence scanner for proteomics studies and early cancer diagnosis , 2002, SPIE/COS Photonics Asia.

[12]  R. D. de Winter,et al.  Value of myoglobin, troponin T, and CK-MBmass in ruling out an acute myocardial infarction in the emergency room. , 1995, Circulation.

[13]  Christophe Leclercq,et al.  2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. , 2012, Heart rhythm.

[14]  Mark A Hlatky,et al.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2013, Circulation.

[15]  Mario Plebani,et al.  Recommendations for the use of cardiac troponin measurement in acute cardiac care. , 2010, European heart journal.

[16]  Hyuk-Jae Chang,et al.  Development of a point-of-care assay system for high-sensitivity C-reactive protein in whole blood. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[17]  Anubhav Jain,et al.  Cardiac Troponins I and T: Molecular Markers for Early Diagnosis, Prognosis, and Accurate Triaging of Patients with Acute Myocardial Infarction , 2012, Molecular Diagnosis & Therapy.

[18]  A. Wu,et al.  Evaluation of imprecision for cardiac troponin assays at low-range concentrations. , 2004, Clinical chemistry.

[19]  Ulrich Friess,et al.  Cardiac markers: a clear cause for point-of-care testing , 2009, Analytical and bioanalytical chemistry.

[20]  Michael Christ,et al.  Cardiac troponin: a critical review of the case for point-of-care testing in the ED. , 2012, The American journal of emergency medicine.

[21]  M. Yılmaz,et al.  Clinical importance of elevated CK-MB and troponin I levels in congestive heart failure , 2006, Advances in therapy.

[22]  S. Sakka,et al.  Prognostic value of serum myoglobin in patients after cardiac surgery , 2007, Journal of Anesthesia.

[23]  A. Singer,et al.  Diagnostic accuracy of a point-of-care troponin I assay for acute myocardial infarction within 3 hours after presentation in early presenters to the emergency department with chest pain. , 2012, American heart journal.

[24]  K. Lackner.  Laboratory diagnostics of myocardial infarction – troponins and beyond , 2013, Clinical chemistry and laboratory medicine.

[25]  F. Apple,et al.  Use of the bioMérieux VIDAS troponin I ultra assay for the diagnosis of myocardial infarction and detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. , 2008, Clinica chimica acta; international journal of clinical chemistry.